Qingling Li

Qingling Li

Auto-generated profile, based on publicly available information

Qingling Li

Anhui University of Chinese Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QLQingling Li
Qingling Li
WWWei Wang
Wei Wang
QMQiang Ma
Qiang Ma
RXRan Xia
Ran Xia
BGBing Gao
Bing Gao
JWJing Wang
Jing Wang
How moxibustion improves chronic heart failure is extremely complex and still unclear. This study aimed to explore whether moxibustion inhibits autophagy and reduces inflammation by regulating mTOR expression to induce myocardial protective effects and alleviate symptoms associated with chronic heart failure. Echocardiography was used to detect cardiac function and cardiac structure of rats, including heart rate (HR), left atrium diameter (LA), left ventricular diameter (LV), left ventricular posterior wall (LVPW), interventricular septum (IVS), ejection fraction (EF), and fractional shortening (FS). BNP and NT-pro BNP levels were measured by enzyme-linked immunosorbent assay (ELISA). Autophagy-associated protein (ATG) genes and mTOR were detected by PCR. The expression of mTOR and phosphorylated-mTOR was detected through western blotting of proteins from myocardial tissue samples. The left ventricular inflammatory response was detected by immunohistochemistry and included ICAM-1, VCAM-1, MMP-2, and MMP-9 expression. The relationship between autophagy and inflammation was analyzed by correlation analysis. The results from echocardiography and ELISA showed that moxibustion could significantly improve heart function and structure. Western blot and PCR results showed that moxibustion treatment elevated mTOR expression. Further, moxibustion could inhibit autophagy and regulate the expression of key autophagy-related genes, including Vps34, ATG3, ATG5, ATG7, ATG12, and ATG13. By contrast, rapamycin could partially reduce the effects of moxibustion. Immunohistochemistry results indicated that moxibustion could reduce myocardial inflammation. Moreover, there was a positive correlation between autophagy and inflammation. Moxibustion can protect cardiac function in rats with heart failure, possibly inhibiting excessive autophagy of cardiomyocytes and reducing inflammatory reactions through the elevation of mTOR expression.

4 June 2025 in Acupuncture & Electro-Therapeutics Research: International Journal of Integrated Medicine
Verified
Journal Article
Closed access
QLQingling Li
Qingling Li
LPLiu Pan
Liu Pan
RXRan Xia
Ran Xia
BGBing Gao
Bing Gao
XJXuezhao Jia
Xuezhao Jia
JWJing Wang
Jing Wang
Background: Impaired energy metabolism is central to chronic heart failure (CHF). While preclinical and clinical studies suggest moxibustion exerts protective effects in CHF, its mechanistic basis—particularly regarding mitochondrial energy regulation—remains poorly understood. Existing work has yet to define whether and how moxibustion modulates key metabolic pathways, such as adenosine 5′-monophosphate-activated protein kinase (AMPK)/PGC-1α signaling, to restore cardiac bioenergetics in CHF. This study tested the hypothesis that moxibustion improves mitochondrial function via AMPK/ PGC-1α activation. Methods: A doxorubicin-induced CHF rat model was established. HE and Masson's trichrome staining were used to observe myocardial morphology and evaluate myocardial fibrosis, respectively. Colorimetry measured myocardial lactate, pyruvate, and ATPase (Na + K + -ATPase, Mg² + -ATPase, Ca² + -ATPase, Ca² + Mg² + -ATPase) activity. Expression levels of the mitochondrial fusion protein mitofusin 2 (MFN2) and the mitochondrial biogenesis proteins mitochondrial transcription factor A (TFAM) and nuclear respiratory factor 1 (NRF1) in cardiomyocytes were detected by Western blotting. AMPK and PGC-1α mRNA expression levels in myocardial tissue were determined by RT-PCR. Results: Moxibustion at the Feishu (BL13) and Xinshu (BL15) acupoints significantly attenuated CHF-related myocardial damage and reduced myocardial fibrosis. Moxibustion also markedly restored ATPase activity and upregulated the expression of the MFN2, NRF1, and TFAM proteins, as well as mRNA levels of AMPK and PGC-1α, in cardiomyocytes from CHF rats. These effects were partially abrogated by administering compound C—a specific AMPK inhibitor. Moreover, a potentially direct interaction between pyruvate and AMPK was predicted through molecular docking analyses. Conclusion: Moxibustion ameliorates CHF by stimulating the AMPK/PGC-1α signaling pathway to improve mitochondrial energy metabolism.